LDL-P should be considered as a primary goal of therapy due to its stronger association with cardiovascular risk.

Cardiovascular Disease

Atherosclerosis is the condition in which the artery wall thickens as the result of the buildup of fatty material such as cholesterol. Management of atherosclerosis is an integral part of clinical practice.

Historically, clinicians manage a patient's risk for cardiovascular disease by measuring plasma lipids such as LDL-C, HDL-C and triglycerides. More recently, it's been shown that measurement of lipoprotein particles, the containers that carry cholesterol, may be beneficial for patient management.
Among cardiometabolic risk (CMR) patients, about two-thirds have high Low Density Lipoprotein particle number (LDL-P) despite optimal levels of LDL-C. For cardiometabolic risk patients, LDL-P should be considered as a primary goal of therapy due to its stronger association with cardiovascular risk.¹

Manage your patients with clarity and confidence with LDL-P by NMR.
1. Rosenson et al. Atherosclerosis. 2010; 213:1-7

===========================================================================================
Read the full article here.